EverSource Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History

EverSource Wealth Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.59K	Buy	794 +68	+9%	+$704	﹤0.01%	3129
2025 Q4	$8.97K	Buy	726 +143	+25%	+$1.53K	﹤0.01%	2855
2025 Q3	$5.14K	Buy	583 +383	+192%	+$2.98K	﹤0.01%	3137
2025 Q2	$1.28K	Buy	200 +114	+133%	+$652	﹤0.01%	3667
2025 Q1	$418	Buy	+86	New	+$712	﹤0.01%	3517
2024 Q1	–	Sell	-210	Closed	-$504	–	2920
2023 Q4	$504	Buy	+210	New	+$494	﹤0.01%	2523
2023 Q3	–	Sell	-206	Closed	-$1.51K	–	2546
2023 Q2	$1.51K	Buy	+206	New	+$1.91K	﹤0.01%	2104
2023 Q1	–	Sell	-443	Closed	-$5.23K	–	2420
2022 Q4	$5.23K	Buy	443 +151	+52%	+$2.34K	﹤0.01%	1583
2022 Q3	$6K	Buy	292 +103	+54%	+$2.87K	﹤0.01%	1285
2022 Q2	$6K	Buy	+189	New	+$6.45K	﹤0.01%	1192

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EverSource Wealth Advisors's EBS Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Emergent Biosolutions (EBS) stake by 9.4% in Q1 2026, buying an estimated $704 and bringing the position to 794 shares worth $6.59K. The position accounts for ﹤0.01% of the portfolio, ranked #3129.

EverSource Wealth Advisors first reported a position in EBS in Q2 2022 and has held it in 10 quarters since. The position peaked at $8.97K in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

EverSource Wealth Advisors held 794 shares of Emergent Biosolutions worth $6.59K as of Q1 2026.
EverSource Wealth Advisors bought 68 Emergent Biosolutions shares in Q1 2026, an estimated $704.
Emergent Biosolutions made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3129 holding.
EverSource Wealth Advisors first reported a position in Emergent Biosolutions in Q2 2022 and has held it in 10 quarters since.
EverSource Wealth Advisors's Emergent Biosolutions position peaked at $8.97K in Q4 2025.
190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.